...
首页> 外文期刊>Lancet Neurology >Occipital nerve stimulation for drug-resistant chronic cluster headache: a prospective pilot study.
【24h】

Occipital nerve stimulation for drug-resistant chronic cluster headache: a prospective pilot study.

机译:枕神经刺激治疗耐药性慢性丛集性头痛:一项前瞻性研究。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

BACKGROUND: Drug-resistant chronic cluster headache (drCCH) is a devastating disorder for which various destructive procedures have been tried unsuccessfully. Occipital nerve stimulation (ONS) is a new, safe strategy for intractable headaches. We undertook a prospective pilot trial of ONS in drCCH to assess clinical efficacy and pain perception. METHODS: Eight patients with drCCH had a suboccipital neurostimulator implanted on the side of the headache and were asked to record details of frequency, intensity, and symptomatic treatment for their attacks in a diary before and after continuous ONS. To detect changes in cephalic and extracephalic pain processing we measured electrical and pressure pain thresholds and the nociceptive blink reflex. FINDINGS: Two patients were pain free after a follow-up of 16 and 22 months; one of them still had occasional autonomic attacks. Three patients had around a 90% reduction in attack frequency. Two patients, one of whom had had the implant for only 3 months, had improvement of around 40%. Mean follow-up was 15.1 months (SD 9.5, range 3-22). Intensity of attacks tends to decrease earlier than frequency during ONS and, on average, is improved by 50% in remaining attacks. All but one patient were able to substantially reduce their preventive drug treatment. Interruption of ONS by switching off the stimulator or because of an empty battery was followed within days by recurrence and increase of attacks in all improved patients. ONS did not significantly modify pain thresholds. The amplitude of the nociceptive blink reflex increased with longer durations of ONS. There were no serious adverse events. INTERPRETATION: ONS could be an efficient treatment for drCCH and could be safer than deep hypothalamic stimulation. The delay of 2 months or more between implantation and significant clinical improvement suggests that the procedure acts via slow neuromodulatory processes at the level of upper brain stem or diencephalic centres.
机译:背景:耐药性慢性丛集性头痛(drCCH)是一种破坏性疾病,其各种破坏性程序均未成功尝试。枕神经刺激(ONS)是治疗顽固性头痛的一种新的安全策略。我们在drCCH中进行了ONS的前瞻性试验,以评估临床疗效和疼痛知觉。方法:八名drCCH患者在头痛的一侧植入了枕下神经刺激器,并被要求在连续ONS之前和之后的日记中记录其发作频率,强度和对症治疗的详细信息。为了检测头痛和脑外疼痛的变化,我们测量了电痛和压力痛阈值以及伤害性眨眼反射。结果:两名患者在进行了16个月和22个月的随访后无疼痛。其中之一仍然偶尔受到自主攻击。三名患者的发作频率降低了约90%。两名患者(其中一名患者仅植入了3个月的植入物)的病情好转了约40%。平均随访15.1个月(SD 9.5,范围3-22)。在ONS期间,攻击强度倾向于比频率降低得更早,并且平均而言,其余攻击可以提高50%。除一名患者外,所有患者均能够大幅减少其预防性药物治疗。在所有改善的患者中,通过关闭刺激器或由于电池电量不足而中断ONS,几天之内就会复发并增加发作。 ONS没有明显改变疼痛阈值。伤害性眨眼反射的幅度随着ONS持续时间的延长而增加。没有严重的不良事件。解释:ONS可能是治疗drCCH的有效方法,并且比深丘脑深部刺激更为安全。植入和临床显着改善之间的延迟2个月或更长时间表明,该程序通过缓慢的神经调节过程在上脑干或双脑中心水平起作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号